We’re pretty positive on it, but one thing bothered us: it was expensive compared to other Snapdragon laptops. But that’s no longer an issue with this sale. Right now, you can get a Galaxy ...

The Snapdragon 8 Gen 3 chipset powers some of the most powerful flagship smartphones, offering exceptional performance, enhanced AI capabilities, and improved graphics. Devices like the Samsung ...

Relmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma. Sepranolone is a neurosteroid being developed as a potential treatment for ...

Relmada Therapeutics (RLMD) announced the acquisition of Sepranolone, a Phase 2b ready neurosteroid, from Asarina Pharma AB, being developed for the potential treatment of Tourette syndrome and ...

After sharing plans to shutter last summer, Asarina Pharma has managed to sell off its Tourette syndrome candidate to Relmada Therapeutics, another struggling biotech. Relmada, which has turned to ...

(RTTNews) - Relmada Therapeutics, Inc. (RLMD), a clinical-stage biotechnology company, on Thursday announced the acquisition of Sepranolone, a Phase 2b-ready neurosteroid, from Asarina Pharma AB.

RELMADA ACQUIRES NEUROSTEROID FROM ASARINA: Relmada Therapeutics (RLMD) announced Thursday the acquisition of Sepranolone, a Phase 2b ready neurosteroid, from Asarina Pharma, being developed for ...

“We are very pleased to announce this agreement with Asarina. Sepranolone aligns with our Company’s mission to find solutions for difficult-to-treat central nervous system (CNS) disorder ...

If you're excited about the upcoming Snapdragon 8 Elite phones, you're in for a treat. There are some seriously powerful devices on the way. The iQOO 13 and OnePlus 13 are just around the corner ...

Relmada Therapeutics has announced the acquisition of Sepranolone, a Phase 2b ready neurosteroid developed for treating Tourette syndrome (TS) and related compulsive disorders, from Asarina Pharma ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled improvement ...